These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14289563)

  • 1. [VERY LONG COMPLETE REMISSIONS OF ACUTE LEUKEMIA].
    BERNARD J; JACQUILLAT C; BOIRON M; NAJEAN Y; SELIGMANN M; WEIL M
    Presse Med (1893); 1965 Feb; 73():457-9. PubMed ID: 14289563
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDY OF FACTORS INFLUENCING SURVIVAL IN ACUTE LEUKEMIAS].
    BERNARD J; BOIRON M; MANUS A; LEVY JP; BRIERE J; DUMONT J
    Schweiz Med Wochenschr; 1964 May; 94():709-14. PubMed ID: 14235201
    [No Abstract]   [Full Text] [Related]  

  • 3. CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. I. RELATIONSHIP TO SYSTEMIC LEUKEMIA AND DESCRIPTION OF CLINICAL AND LABORATORY MANIFESTATIONS.
    HYMAN CB; BOGLE JM; BRUBAKER CA; WILLIAMS K; HAMMOND D
    Blood; 1965 Jan; 25():1-12. PubMed ID: 14255969
    [No Abstract]   [Full Text] [Related]  

  • 4. IMPLICATIONS OF LONG-TERM SURVIVAL IN ACUTE STEM CELL LEUKEMIA OF CHILDHOOD TREATED WITH COMPOSITE CYCLIC THERAPY.
    ZUELZER WW
    Blood; 1964 Nov; 24():477-94. PubMed ID: 14236724
    [No Abstract]   [Full Text] [Related]  

  • 5. [LONG-TERM REMISSIONS OF ACUTE LEUKEMIAS IN CHILDHOOD].
    GASSER C
    Med Klin; 1964 Mar; 59():385-93. PubMed ID: 14176488
    [No Abstract]   [Full Text] [Related]  

  • 6. ACUTE MONOCYTIC LEUKAEMIA WITH RESPONSE TO METHOTREXATE.
    DUBOWITZ V
    Arch Dis Child; 1964 Jun; 39(205):289-92. PubMed ID: 14169462
    [No Abstract]   [Full Text] [Related]  

  • 7. ACUTE LEUKEMIA TREATED WITH DIVIDED DOSES OF METHOTREXATE.
    HUGULEY CM; VOGLER WR; LEA JW; CORLEY CC; LOWREY ME
    Arch Intern Med; 1965 Jan; 115():23-8. PubMed ID: 14222475
    [No Abstract]   [Full Text] [Related]  

  • 8. 50 Years Ago in TheJournal ofPediatrics: Induction of Remission in Acute Leukemia of Childhood by Combination of Prednisone and Either 6-Mercaptopurine or Methotrexate.
    Vitanza NA
    J Pediatr; 2016 Jun; 173():100. PubMed ID: 27234282
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
    Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
    N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
    KEIDAN SE; MAINWARING D
    Clin Pediatr (Phila); 1965 Jan; 4():13-7. PubMed ID: 14243915
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF ACUTE LEUKEMIA ACCORDING TO ENZYMATOLOGIC PRINCIPLES].
    WILMANNS W
    Dtsch Med Wochenschr; 1965 May; 90():887-8. PubMed ID: 14282236
    [No Abstract]   [Full Text] [Related]  

  • 12. RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
    SMITH JC; BOLANDE RP
    Arch Pathol; 1965 Mar; 79():310-6. PubMed ID: 14246210
    [No Abstract]   [Full Text] [Related]  

  • 13. THE PERSISTENCE OF EXTRAMEDULLARY LEUKEMIC INFILTRATES DURING BONE MARROW REMISSION OF ACUTE LEUKEMIA.
    NIES BA; BODEY GP; THOMAS LB; BRECHER G; FREIREICH EJ
    Blood; 1965 Aug; 26():133-41. PubMed ID: 14335085
    [No Abstract]   [Full Text] [Related]  

  • 14. CHICKENPOX IN LEUKEMIC PATIENTS--FACTORS IN PROGNOSIS.
    BODEY G; MCKELVEY E; KARON M
    Pediatrics; 1964 Oct; 34():562-4. PubMed ID: 14212473
    [No Abstract]   [Full Text] [Related]  

  • 15. ACUTE LEUKEMIA IN ADOLESCENTS AND ADULTS. RESULTS OF TREATMENT OVER THREE CONSECUTIVE 5-YEAR PERIODS.
    MEYERS MC; HINES DR; BISHOP RC
    Ann Intern Med; 1965 Sep; 63():411-5. PubMed ID: 14330591
    [No Abstract]   [Full Text] [Related]  

  • 16. THE TREATMENT OF ACUTE LEUKAEMIA ON THE BASIS OF ENZYME ACTIVITY.
    WILMANNS W
    Ger Med Mon; 1965 Jul; 10():291-2. PubMed ID: 14341999
    [No Abstract]   [Full Text] [Related]  

  • 17. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
    Mahoney DH; Shuster J; Nitschke R; Lauer SJ; Winick N; Steuber CP; Camitta B
    J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X.
    Pui CH; Simone JV; Hancock ML; Evans WE; Williams DL; Bowman WP; Dahl GV; Dodge RK; Ochs J; Abromowitch M
    Leukemia; 1992 Feb; 6(2):150-7. PubMed ID: 1552746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. II. THERAPY WITH INTRATHECAL METHOTREXATE.
    HYMAN CB; BOGLE JM; BRUBAKER CA; WILLIAMS K; HAMMOND D
    Blood; 1965 Jan; 25():13-22. PubMed ID: 14255968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.